CXCL8 and lip and oral cavity carcinoma: On the contrary, Gross et al. found that inhibition of JNK suppresses tumor growth in oral cancer by downregulating IL-8 signaling, VEGF activity, and EGFR activation [167], suggesting JNK’s pro-oncogenic role in oral cancer.